Keyphrases
Acute Infective Endocarditis
31%
Adverse Drug Events
17%
Antibiotics
21%
Bisphosphonate Therapy
19%
Bisphosphonates
29%
Bloodstream Infection
23%
Cellulitis
18%
Co-prescription
16%
Confidence Interval
58%
Daptomycin
31%
Department of Defense
27%
Department of Veterans Affairs
22%
Diabetic
17%
Disease Outcome
34%
Endocarditis
22%
Enterococcal Endocarditis
16%
Enterococcus
24%
Genitourinary Injury
16%
Hazard Ratio
59%
Heart Valve Prosthesis
16%
High Risk
31%
Hospitalization
31%
Infectious Complications
47%
Infectious Diseases
38%
Infective Endocarditis
58%
Inter-institutional
15%
International Collaboration on Endocarditis
31%
Kidney Function
23%
Methicillin-resistant Staphylococcus Aureus
31%
Military Personnel
24%
Mycobacterium Intracellulare
31%
Myocardial Infarction
31%
National Cohort
48%
Odds Ratio
16%
Osteomyelitis
75%
Retrospective Cohort Study
31%
Rheumatoid Arthritis
92%
Rheumatoid Arthritis Patients
16%
Risk Factors
47%
Risk of Death
28%
TNF-α Antagonists
24%
Trauma
47%
Trauma-related Infections
25%
Tumor Necrosis Factor-α
17%
Urinary Tract Infection
18%
US Military
16%
Vancomycin
47%
Veterans Affairs
50%
Veterans Health Administration
26%
Warfarin
31%
Medicine and Dentistry
Adverse Drug Reaction
17%
Antibiotic Resistance
15%
Bisphosphonate
23%
Bloodstream Infection
31%
Cardiovascular System
15%
Cellulitis
15%
Clostridium Difficile Infection
23%
Community-Acquired Pneumonia
15%
Congestive Heart Failure
23%
Coronavirinae
15%
COVID-19 Vaccine
15%
Disease
51%
Disseminated Herpes Zoster
15%
Diuresis
15%
Endocarditis
47%
Endoscopic Retrograde Cholangiopancreatography
15%
Genitourinary Trauma
16%
Glomerular Filtration Rate
15%
Hazard Ratio
23%
Health Care
19%
Health Care Facility
15%
Heart Valve Prosthesis
16%
Human Immunodeficiency Virus
15%
Infection
95%
Infectious Complication
47%
Infective Endocarditis
58%
Inflammatory Arthritis
60%
Injury
53%
Internal Transcribed Spacer
15%
Joint Injection
15%
Kidney Function
31%
Masking
15%
Mental Disorder
15%
Musculoskeletal Pain
15%
Mycobacterium Avium Complex
31%
Myocardial Infarction
15%
Non Melanoma Skin Cancer
15%
Observational Study
16%
Osteomyelitis
41%
Outpatient
38%
Peptoclostridium difficile
15%
Prevalence
30%
Rheumatoid Arthritis
60%
Septic Arthritis
15%
Silo-Filler's Disease
15%
Surveillance System
15%
Treatment Duration
15%
Tumor Necrosis Factor
25%
Urinary Tract Infection
17%
Veterans Affairs
61%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Failure
15%
Acute Kidney Failure
15%
Adverse Drug Reaction
17%
Antibiotic Resistance
15%
Antibiotics
15%
Antiinfective Agent
15%
Antimicrobial Resistance
15%
Bacterial Endocarditis
27%
Bisphosphonic Acid Derivative
39%
Cancer Mortality
15%
Cancer Recurrence
15%
Cardiovascular Disease
11%
Case-Control Study
15%
Cefepime
15%
Cohort Study
33%
Community Acquired Pneumonia
15%
Congestive Heart Failure
19%
COVID-19 Vaccine
15%
Daptomycin
31%
Diabetes Mellitus
17%
Diarrhea
15%
Diffuse Large B Cell Lymphoma
15%
Disease
41%
Diuretic Agent
10%
Endocarditis
15%
Gram Negative Bacterium
15%
Head and Neck Cancer
15%
Heart Infarction
31%
Herpes Zoster
15%
HIV
15%
Immunosuppressive Agent
9%
Infection
100%
Infectious Complication
31%
Infectious Diarrhea
15%
Inflammatory Arthritis
93%
Injury
31%
Lactam
15%
Methicillin-Resistant Staphylococcus Aureus
15%
Musculoskeletal Pain
15%
Non Melanoma Skin Cancer
15%
Obesity
15%
Observational Study
16%
Osteomyelitis
42%
Peripheral Occlusive Artery Disease
19%
Piperacillin Plus Tazobactam
15%
Recurrent Disease
13%
Rheumatoid Arthritis
93%
Tumor Necrosis Factor
57%
Vancomycin
47%
Warfarin
31%
